Reprint

Role of NO in Disease: Good, Bad or Ugly

Edited by
July 2024
166 pages
  • ISBN978-3-7258-1563-0 (Hardback)
  • ISBN978-3-7258-1564-7 (PDF)

This is a Reprint of the Special Issue Role of NO in Disease: Good, Bad or Ugly that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This Special Issue of Biomedicines, “Role of NO in Disease: Good, Bad or Ugly”, focuses on the roles of nitric oxide (NO) in disease from various aspects. NO plays an important role in several physiological processes with numerous biological targets, such as cardiovascular homeostasis, angiogenesis, neural signaling, inflammatory processes, and immune regulation. Hence, it is obvious that essentially all cells and biological activities are modulated by NO. This reactive and toxic two-atom gaseous molecule has an unpaired electron and is therefore considered a free radical. It is one of the most important signaling molecules. NO was most likely generated by volcanic emissions in the early atmosphere, from CO2 and N2, approximately 4.5 billion years ago, long before the appearance of the living organisms that now contribute significantly to the cycling of nitrogen species. Endogenous NO is catalyzed from L-arginine by mammalian nitric oxide synthases (NOS). However, NOS-like enzymes have also been found in procaryotes, bacteria, and eukaryotes, suggesting a basic role of NO in the evolutionary process. Thus, it is not surprising that NO signaling is spread throughout the entire phylogenetic scale.

Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
nitric oxide; COVID-19; acute respiratory syndrome coronavirus 2; inhaled nitric oxide therapy; endothelium; vascular function; obesity; nitric oxide; adiponectin; SIRT1; nitric oxide; sensors; macrophages; atherosclerosis; UVA; nitrite; cold atmospheric plasma; nitric oxide donor; skin; wound healing; microcirculation; COPD; fraction exhaled nitric oxide and lung function tests; comorbidity; GOLD; mathematical model; gas exchange; nitric oxide; disease; chronic granulomatous disease; bladder cancer; furoxans; nitric oxide donors; NF-κB; survivin; renin; hypoxia; HIFs; juxtaglomerular cells; nitric oxide; rheumatoid arthritis; free secretory component; ACPA; exhaled nitric oxide; lung; pathogenesis; rheumatoid factor; breastfeeding; human milk; nitrate; nitric oxide; nitrite; saliva; n/a